{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:50:04Z","timestamp":1793670604944,"version":"4.5.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002424","name":"Fujifilm Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We aimed to investigate the value of computed tomography (CT)-based radiomics with artificial intelligence (AI) in predicting pathological lymph node metastasis (pN) in patients with clinical stage 0\u2013IA non-small cell lung cancer (\n                    <jats:italic>c<\/jats:italic>\n                    -stage 0\u2013IA NSCLC). This study enrolled 720 patients who underwent complete surgical resection for\n                    <jats:italic>c<\/jats:italic>\n                    -stage 0\u2013IA NSCLC, and were assigned to the derivation and validation cohorts. Using the AI software Beta Version (Fujifilm Corporation, Japan), 39 AI imaging factors, including 17 factors from the AI ground-glass nodule analysis and 22 radiomics features from nodule characterization analysis, were extracted to identify factors associated with pN. Multivariate analysis showed that clinical stage IA3 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.028), solid-part size (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), and average solid CT value (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.033) were independently associated with pN. The receiver operating characteristic analysis showed that the area under the curve and optimal cut-off values of the average solid CT value relevant to pN were 0.761 and -103 Hounsfield units, and the threshold provided sensitivity, specificity, and negative predictive values of 69%, 65%, and 94% in the entire cohort, respectively. Measuring the average solid-CT value of tumors for pN may have broad applications such as guiding individualized surgical approaches and postoperative treatment.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-28242-7","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:06:06Z","timestamp":1674108366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Artificial intelligence-based radiomics for the prediction of nodal metastasis in early-stage lung cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Yoshihisa","family":"Shimada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachio","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Fukuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"Masuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"28242_CR1","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1097\/JTO.0000000000000678","volume":"10","author":"H Asamura","year":"2015","unstructured":"Asamura, H. et al. The international association for the study of lung cancer lung cancer staging project: Proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J. Thorac. Oncol. 10, 1675\u201384 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"28242_CR2","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S0022-5223(96)70213-1","volume":"111","author":"H Asamura","year":"1996","unstructured":"Asamura, H. et al. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy?. J. Thorac. Cardiovasc. Surg. 111, 1125\u20131134 (1996).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"28242_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.athoracsur.2013.03.050","volume":"96","author":"S Cho","year":"2013","unstructured":"Cho, S. et al. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer. Ann. Thorac. Surg. 96, 239\u2013245 (2013).","journal-title":"Ann. Thorac. Surg."},{"key":"28242_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/JTO.0b013e31825871de","volume":"7","author":"T Koike","year":"2012","unstructured":"Koike, T. et al. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. J. Thorac. Oncol. 7, 1246\u20131251 (2012).","journal-title":"J. Thorac. Oncol."},{"key":"28242_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.lungcan.2013.04.012","volume":"81","author":"L Li","year":"2013","unstructured":"Li, L. et al. Risk factors for predicting the occult nodal metastasis in T1\u20132N0M0 NSCLC patients staged by PET\/CT: Potential value in the clinic. Lung Cancer 81, 213\u2013217 (2013).","journal-title":"Lung Cancer"},{"key":"28242_CR6","first-page":"CD009519","volume":"11","author":"M Schmidt-Hansen","year":"2014","unstructured":"Schmidt-Hansen, M. et al. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst. Rev. 11, CD009519 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"28242_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/resp.13162","volume":"23","author":"MR Vial","year":"2018","unstructured":"Vial, M. R. et al. Diagnostic performance of endobronchial ultrasound-guided mediastinal lymph node sampling in early stage non-small cell lung cancer: A prospective study. Respirology 23, 76\u201381 (2018).","journal-title":"Respirology"},{"issue":"4","key":"28242_CR8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.athoracsur.2019.04.082","volume":"108","author":"Y Shimada","year":"2019","unstructured":"Shimada, Y. et al. Computed tomography histogram approach to predict lymph node metastasis in patients with clinical stage IA lung cancer. Ann. Thorac. Surg. 108(4), 1021\u20138. https:\/\/doi.org\/10.1016\/j.athoracsur.2019.04.082 (2019).","journal-title":"Ann. Thorac. Surg."},{"key":"28242_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/ejcts\/ezab541","volume":"61","author":"Y Kudo","year":"2022","unstructured":"Kudo, Y. et al. Artificial intelligence analysis of three-dimensional imaging data derives factors associated with postoperative recurrence in patients with radiologically solid-predominant small-sized lung cancers. Eur. J. Cardiothorac. Surg. 61, 751\u2013760 (2022).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"28242_CR10","doi-asserted-by":"publisher","first-page":"e001752","DOI":"10.1136\/jitc-2020-001752","volume":"9","author":"RR Colen","year":"2021","unstructured":"Colen, R. R. et al. Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. J. Immunother. Cancer. 9, e001752 (2021).","journal-title":"J. Immunother. Cancer."},{"key":"28242_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.athoracsur.2020.01.010","volume":"109","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. Radiomics signature predicts the recurrence-free survival in stage I non-small cell lung cancer. Ann. Thorac. Surg. 109, 1741\u20131749 (2020).","journal-title":"Ann. Thorac. Surg."},{"key":"28242_CR12","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1007\/s00330-020-06776-y","volume":"30","author":"Y Sun","year":"2020","unstructured":"Sun, Y. et al. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: Invasive prediction. Eur. Radiol. 30, 3650\u20133659 (2020).","journal-title":"Eur. Radiol."},{"key":"28242_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lungcan.2019.11.003","volume":"139","author":"M Cong","year":"2020","unstructured":"Cong, M. et al. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer. Lung Cancer 139, 73\u201379 (2020).","journal-title":"Lung Cancer"},{"key":"28242_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/ejcts\/ezaa011","volume":"58","author":"D Chen","year":"2020","unstructured":"Chen, D. et al. Radiomics-based prediction for tumour spread through air spaces in stage I lung adenocarcinoma using machine learning. Eur. J. Cardiothorac. Surg. 58, 51\u201358 (2020).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"28242_CR15","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1007\/s00268-016-3652-5","volume":"40","author":"K Kaseda","year":"2016","unstructured":"Kaseda, K. et al. Risk factors for predicting occult lymph node metastasis in patients with clinical stage I non-small cell lung cancer staged by integrated fluorodeoxyglucose positron emission tomography\/computed tomography. World J. Surg. 40, 2976\u20132983 (2016).","journal-title":"World J. Surg."},{"key":"28242_CR16","doi-asserted-by":"publisher","first-page":"e104066","DOI":"10.1371\/journal.pone.0104066","volume":"9","author":"JY Son","year":"2014","unstructured":"Son, J. Y. et al. Quantitative CT analysis of pulmonary ground-glass opacity nodules for the distinction of invasive adenocarcinoma from pre-invasive or minimally invasive adenocarcinoma. PLoS ONE 9, e104066 (2014).","journal-title":"PLoS ONE"},{"key":"28242_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.lungcan.2018.08.027","volume":"125","author":"D Eriguchi","year":"2018","unstructured":"Eriguchi, D. et al. Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET. Lung Cancer 125, 14\u201321 (2018).","journal-title":"Lung Cancer"},{"key":"28242_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1378\/chest.15-0034","volume":"149","author":"SH Bak","year":"2016","unstructured":"Bak, S. H. et al. Quantitative CT scanning analysis of pure ground-glass opacity nodules predicts further CT scanning change. Chest. 149, 180\u201391 (2016).","journal-title":"Chest."},{"key":"28242_CR19","doi-asserted-by":"publisher","first-page":"e0172433","DOI":"10.1371\/journal.pone.0172433","volume":"12","author":"N Tsuchiya","year":"2017","unstructured":"Tsuchiya, N., Doai, M., Usuda, K., Uramoto, H. & Tonami, H. Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion. PLoS ONE 12, e0172433 (2017).","journal-title":"PLoS ONE"},{"key":"28242_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.lungcan.2017.09.001","volume":"113","author":"A Hattori","year":"2017","unstructured":"Hattori, A. et al. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography. Lung Cancer 113, 7\u201313 (2017).","journal-title":"Lung Cancer"},{"key":"28242_CR21","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.jtcvs.2017.08.037","volume":"154","author":"A Hattori","year":"2017","unstructured":"Hattori, A. et al. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 154, 2102\u20132110 (2017).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"28242_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.lungcan.2018.05.001","volume":"121","author":"H Furumoto","year":"2018","unstructured":"Furumoto, H. et al. Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung. Lung Cancer 121, 91\u201396 (2018).","journal-title":"Lung Cancer"},{"key":"28242_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lungcan.2013.11.025","volume":"83","author":"K Kaira","year":"2014","unstructured":"Kaira, K. et al. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer. Lung Cancer 83, 197\u2013204 (2014).","journal-title":"Lung Cancer"},{"key":"28242_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.athoracsur.2017.01.076","volume":"104","author":"A Hattori","year":"2017","unstructured":"Hattori, A. et al. Importance of ground glass opacity component in clinical stage IA radiologic invasive lung cancer. Ann. Thorac. Surg. 104, 313\u2013320 (2017).","journal-title":"Ann. Thorac. Surg."},{"key":"28242_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.athoracsur.2016.02.074","volume":"102","author":"A Hattori","year":"2016","unstructured":"Hattori, A. et al. Neither maximum tumor size nor solid component size is prognostic in part-solid lung cancer: Impact of tumor size should be applied exclusively to solid lung cancer. Ann. Thorac. Surg. 102, 407\u2013415 (2016).","journal-title":"Ann. Thorac. Surg."},{"issue":"Suppl 7","key":"28242_CR26","doi-asserted-by":"publisher","first-page":"S807","DOI":"10.21037\/jtd.2018.03.126","volume":"10","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. A new approach to predict lymph node metastasis in solid lung adenocarcinoma: A radiomics nomogram. J. Thorac. Dis. 10(Suppl 7), S807\u2013S819 (2018).","journal-title":"J. Thorac. Dis."},{"key":"28242_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2214\/AJR.17.19074","volume":"211","author":"Y Zhong","year":"2018","unstructured":"Zhong, Y. et al. Radiomics approach to prediction of occult mediastinal lymph node metastasis of lung adenocarcinoma. AJR Am. J. Roentgenol. 211, 109\u2013113 (2018).","journal-title":"AJR Am. J. Roentgenol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28242-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28242-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28242-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:15:25Z","timestamp":1674108925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28242-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28242"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28242-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2074977\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"assertion":[{"value":"17 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Shimada, Dr. Kudo, Dr. Maehara, Dr. Masuno, Dr. Fukuta, and Dr. Park have no conflicts to disclose. Dr. Ikeda reports grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Chugai Pharma, grants and personal fees from Eli Lilly, grants and personal fees from MSD, grants and personal fees from Nihon Medi-Physics, grants and personal fees from Ono Pharmaceutical, grants and personal fees from Pfizer, grants and personal fees from Taiho Pharmaceutical, grants and personal fees from Teijin, and personal fees from Bristol-Meyers Squibb Japan outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1028"}}